These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23533977)

  • 1. Championing ethics: industry viewpoint.
    Menon S; Rai K
    Perspect Clin Res; 2013 Jan; 4(1):33-8. PubMed ID: 23533977
    [No Abstract]   [Full Text] [Related]  

  • 2. Maori-centred codes of ethics: championing inclusiveness in creating professional codes of ethics across the New Zealand health sector.
    Smith B
    N Z Med J; 2014 Jul; 127(1397):9-12. PubMed ID: 24997697
    [No Abstract]   [Full Text] [Related]  

  • 3. [Future requirements for the composition and working methods of ethics commissions for the viewpoint of the Association of Physicians in the Pharmaceutical Industry e. V.(FAPI)].
    Schwarz JA; Gladigau V; Görlich HD; Klingmann I; Kori-Lindner C; Langen ML; Mangold B; Neis W; Schenk J; Uehleke B
    Arzneimittelforschung; 1990 Sep; 40(9):1056-60. PubMed ID: 2080944
    [No Abstract]   [Full Text] [Related]  

  • 4. Championing change: an interview with Bell Atlantic's CEO Raymond Smith. Interview by Rosabeth Moss Kanter.
    Smith R
    Harv Bus Rev; 1991; 69(1):118-30. PubMed ID: 10109468
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials of drugs from the viewpoint of the pharmaceutical industry.
    Peltier HC
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 2):637-42. PubMed ID: 1102239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Responsibility for patient education in drug therapy from the viewpoint of the pharmaceutical industry].
    Sander A
    Z Arztl Fortbild (Jena); 1994 Dec; 88(12):1061-3. PubMed ID: 7716983
    [No Abstract]   [Full Text] [Related]  

  • 7. The teaching of medical ethics from a junior doctor's viewpoint.
    Law SA
    J Med Ethics; 1985 Mar; 11(1):37-8. PubMed ID: 3981571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Responsibility for patient education in drug therapy from the viewpoint of the drug industry].
    Lerch C
    Z Arztl Fortbild (Jena); 1994 Dec; 88(12):1055-60. PubMed ID: 7716982
    [No Abstract]   [Full Text] [Related]  

  • 9. [Euthanasia from the viewpoint of ethics (author's transl)].
    Yan CY
    Hu Li Za Zhi; 1975 Apr; 22(2):1-3. PubMed ID: 1042081
    [No Abstract]   [Full Text] [Related]  

  • 10. Health orphans: the academic viewpoint.
    Walshe JM
    J R Coll Physicians Lond; 1988 Jul; 22(3):177-9. PubMed ID: 3411545
    [No Abstract]   [Full Text] [Related]  

  • 11. Championing cardiovascular health innovation in Europe.
    Komajda M; Coats A; Cowie MR; Jackson N; Svensson A; Vardas P;
    Eur Heart J; 2013 Sep; 34(33):2630-5. PubMed ID: 23832552
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ethics and problems of working with experimental animals in biology and medicine from the viewpoint of a veterinarian].
    Jelínek F
    Cesk Patol; 1994 Aug; 30(3):75. PubMed ID: 7923419
    [No Abstract]   [Full Text] [Related]  

  • 13. Are ethics of industry appropriate to medical care?
    Bates D
    Hosp Trustee; 1979; 3(5):11-4. PubMed ID: 10244526
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics research begets questions: biotech industry seeks ethics advice to deal with complex issues.
    Day K
    N Y Times Web; 1996 May; ():A1, A20-21. PubMed ID: 11647102
    [No Abstract]   [Full Text] [Related]  

  • 15. Commercial and non-commercial 'championing' of medications.
    Parry P
    Aust N Z J Psychiatry; 2010 Jun; 44(6):585. PubMed ID: 20482422
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculosis in industry from the viewpoint of the physician in industry.
    POLLAK M
    Occup Med (Chic Ill); 1946 Mar; 1():302-10. PubMed ID: 21023901
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis in industry from the viewpoint of the physician in industry.
    POLLAK M
    Proc Inst Med Chic; 1946 Jan; 16():29-31. PubMed ID: 21011407
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploring the Factors Triggering Occupational Ethics Risk of Technology Transaction in Chinese Construction Industry.
    Liu X; Lin S; Liu L; Qian F; Zhang K
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32059596
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug research in Germany--problems and chances--from the viewpoint of the drug industry].
    Weihrauch TR; Baumbauer E
    Arzneimittelforschung; 1998 Nov; 48(11):1047-50. PubMed ID: 9850422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical ethics from the historical viewpoint].
    BUESS H
    Praxis; 1959 Nov; 48():1029-32. PubMed ID: 13805727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.